Program
Discovery
Preclinical
PHASE I
PHASE II
PHASE III
Partner Phase
SL-279252 (PD1 // 0X40L)
PHASE I

Clinical studies are ongoing for patients with multiple cancer types in the US, Canada and Europe

partner
SL-172154 (SIRPA // CD40L)
PRECLINICAL

Clinical studies will be initiated shortly

partner
SL-115154 (CSFIR // CD40L)
PRECLINICAL

Clinical studies will be initiated shortly

partner
Undisclosed Targets
PRECLINICAL

partner